MacroGenics Total Long-Term Assets 2012-2025 | MGNX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MacroGenics total long-term assets from 2012 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MacroGenics total long-term assets from 2012 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$215.2B
Boston Scientific (BSX)	$153.3B
Stryker (SYK)	$148.6B
EssilorLuxottica (ESLOY)	$131.1B
Medtronic (MDT)	$114.9B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$43.1B
ResMed (RMD)	$37.8B
GE HealthCare Technologies (GEHC)	$34.8B
Agilent Technologies (A)	$32.4B
Terumo (TRUMY)	$23.9B
Koninklijke Philips (PHG)	$23.7B
Insulet (PODD)	$20B
Zimmer Biomet Holdings (ZBH)	$18.4B
Baxter (BAX)	$14.3B
Smith & Nephew SNATS (SNN)	$13.2B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$4.9B
Prestige Consumer Healthcare (PBH)	$3.7B
Perrigo (PRGO)	$3.7B
Haemonetics (HAE)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.7B
AtriCure (ATRC)	$1.4B
Acuren (TIC)	$1.4B